Exact Mass: 903.3277333999998

Exact Mass Matches: 903.3277333999998

Found 8 metabolites which its exact mass value is equals to given mass value 903.3277333999998, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   

Amanin|cyclo-(L-alpha-aspartyl->trans-4-hydroxy-L-prolyl->(4R)-4,5-dihydroxy-L-isoleucyl->2-mercapto-L-tryptophyl->glycyl->L-isoleucyl->glycyl->L-cysteinyl) [4]->[8]-(R)-sulfoxide|[1-(L-aspartic acid)]-[4]6-deoxy-alpha-amanitin

Amanin|cyclo-(L-alpha-aspartyl->trans-4-hydroxy-L-prolyl->(4R)-4,5-dihydroxy-L-isoleucyl->2-mercapto-L-tryptophyl->glycyl->L-isoleucyl->glycyl->L-cysteinyl) [4]->[8]-(R)-sulfoxide|[1-(L-aspartic acid)]-[4]6-deoxy-alpha-amanitin

C39H53N9O14S (903.3432518)


   
   

MitoTam (bromide, hydrobromide)

MitoTam (bromide, hydrobromide)

C52H60Br2NOP (903.2778999999999)


MitoTam bromide, hydrobromide, a Tamoxifen derivative[1], is an electron transport chain (ETC) inhibitor. MitoTam bromide, hydrobromide reduces mitochondrial membrane potential in senescent cells and affects mitochondrial morphology[2]. MitoTam bromide, hydrobromide is an effective anticancer agent, suppresses respiratory complexes (CI-respiration) and disrupts respiratory supercomplexes (SCs) formation in breast cancer cells[1][2].

   

4-(carboxymethyl)-2,8,11,14,22,30,33,36,39-nonahydroxy-13-(3-hydroxybutan-2-yl)-5-oxo-34-(sec-butyl)-27-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.0⁶,¹⁰.0¹⁸,²⁶.0¹⁹,²⁴]nonatriaconta-2,11,14,18(26),19,21,23,29,32,35,38-undecaen-27-ium-27-olate

4-(carboxymethyl)-2,8,11,14,22,30,33,36,39-nonahydroxy-13-(3-hydroxybutan-2-yl)-5-oxo-34-(sec-butyl)-27-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.0⁶,¹⁰.0¹⁸,²⁶.0¹⁹,²⁴]nonatriaconta-2,11,14,18(26),19,21,23,29,32,35,38-undecaen-27-ium-27-olate

C39H53N9O14S (903.3432518)


   

(1s,4s,8r,10s,13s,16s,34s)-34-[(2s)-butan-2-yl]-4-(carboxymethyl)-13-[(2r,3r)-3,4-dihydroxybutan-2-yl]-2,8,11,14,30,33,36,39-octahydroxy-5-oxo-27-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.0⁶,¹⁰.0¹⁸,²⁶.0¹⁹,²⁴]nonatriaconta-2,11,14,18(26),19,21,23,29,32,35,38-undecaen-27-ium-27-olate

(1s,4s,8r,10s,13s,16s,34s)-34-[(2s)-butan-2-yl]-4-(carboxymethyl)-13-[(2r,3r)-3,4-dihydroxybutan-2-yl]-2,8,11,14,30,33,36,39-octahydroxy-5-oxo-27-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.0⁶,¹⁰.0¹⁸,²⁶.0¹⁹,²⁴]nonatriaconta-2,11,14,18(26),19,21,23,29,32,35,38-undecaen-27-ium-27-olate

C39H53N9O14S (903.3432518)


   

2-({[1-({2-[1-(6-hydroxy-1,1-dimethyl-3,4-dihydro-2h-isoquinolin-3-yl)-n-methylformamido]-1-({[(2e,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl}-c-hydroxycarbonimidoyl)-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid

2-({[1-({2-[1-(6-hydroxy-1,1-dimethyl-3,4-dihydro-2h-isoquinolin-3-yl)-n-methylformamido]-1-({[(2e,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl}-c-hydroxycarbonimidoyl)-3-(methylsulfanyl)propyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid

C43H53N9O11S (903.3585068)